{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T08:18:56Z","timestamp":1782548336791,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.pnpbp.2017.06.030","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T06:01:54Z","timestamp":1498543314000},"page":"213-219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"PB","title":["Pregnancy exposure to citalopram \u2013 Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4198-5160","authenticated-orcid":false,"given":"Michael","family":"Paulzen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamme W.","family":"Goecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia C.","family":"Stingl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geer","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmar","family":"Stickeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Gr\u00fcnder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3851-4117","authenticated-orcid":false,"given":"Georgios","family":"Schoretsanitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2017.06.030_bb0005","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1056\/NEJMoa066584","article-title":"National Birth Defects Prevention S. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects","volume":"356","author":"Alwan","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0010","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s40263-016-0338-3","article-title":"Safety of selective serotonin reuptake inhibitors in pregnancy: a review of current evidence","volume":"30","author":"Alwan","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0015","author":"Aston"},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0020","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/01.psy.0000244025.20549.bd","article-title":"Prenatal depression, prenatal anxiety, and spontaneous preterm birth: a prospective cohort study among women with early and regular care","volume":"68","author":"Dayan","year":"2006","journal-title":"Psychosom. Med."},{"issue":"Suppl. 20","key":"10.1016\/j.pnpbp.2017.06.030_bb0025","first-page":"85","article-title":"Differential pharmacology of newer antidepressants","volume":"59","author":"DeVane","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.earlhumdev.2008.07.002","article-title":"Prenatal depression restricts fetal growth","volume":"85","author":"Diego","year":"2009","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0035","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/070674370905400405","article-title":"Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study","volume":"54","author":"Einarson","year":"2009","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0040","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/bmj.323.7307.257","article-title":"Cohort study of depressed mood during pregnancy and after childbirth","volume":"323","author":"Evans","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0045","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40262-014-0233-3","article-title":"Placental transfer of antidepressant medications: implications for postnatal adaptation syndrome","volume":"54","author":"Ewing","year":"2015","journal-title":"Clin. Pharmacokinet."},{"issue":"497","key":"10.1016\/j.pnpbp.2017.06.030_bb0050","first-page":"e491","article-title":"Bupropion therapy during pregnancy: the drug and its major metabolites in umbilical cord plasma and amniotic fluid","volume":"215","author":"Fokina","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0055","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1517\/17425255.2012.699041","article-title":"Current toxicological aspects on drug and chemical transport and metabolism across the human placental barrier","volume":"8","author":"Giaginis","year":"2012","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0060","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archgenpsychiatry.2010.111","article-title":"A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction","volume":"67","author":"Grote","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0065","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1471-2393-14-242","article-title":"Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance","volume":"14","author":"Hanley","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0070","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1067\/mcp.2002.126181","article-title":"Citalopram in pregnancy and lactation","volume":"72","author":"Heikkinen","year":"2002","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0075","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1176\/appi.ajp.160.5.993","article-title":"Placental passage of antidepressant medications","volume":"160","author":"Hendrick","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0080","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/cpt.147","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors","volume":"98","author":"Hicks","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"issue":"10","key":"10.1016\/j.pnpbp.2017.06.030_bb0090","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0006-3223(00)00958-6","article-title":"Amniotic fluid and umbilical cord blood concentrations of antidepressants in three women","volume":"48","author":"Hostetter","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0095","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/clpt.2011.66","article-title":"The human placental perfusion model: a systematic review and development of a model to predict in vivo transfer of therapeutic drugs","volume":"90","author":"Hutson","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0100","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.genhosppsych.2012.12.010","article-title":"National trends in antidepressant medication treatment among publicly insured pregnant women","volume":"35","author":"Huybrechts","year":"2013","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0105","first-page":"B4916","article-title":"Exposure to antidepressants during pregnancy\u2014prevalences and outcomes","volume":"61","author":"Jimenez-Solem","year":"2014","journal-title":"Dan. Med. J."},{"issue":"10","key":"10.1016\/j.pnpbp.2017.06.030_bb0110","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3390\/ph6101221","article-title":"The use of central nervous system active drugs during pregnancy","volume":"6","author":"Kallen","year":"2013","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0115","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S2215-0366(16)00003-1","article-title":"Suicide in perinatal and non-perinatal women in contact with psychiatric services: 15year findings from a UK national inquiry","volume":"3","author":"Khalifeh","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/acps.12479","article-title":"Use of psychotropic drugs during pregnancy and breast-feeding","volume":"132","author":"Larsen","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1176\/appi.ajp.163.1.145","article-title":"Antidepressants in amniotic fluid: another route of fetal exposure","volume":"163","author":"Loughhead","year":"2006","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0130","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1056\/NEJMoa067407","article-title":"First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects","volume":"356","author":"Louik","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0135","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/sper.2001.24901","article-title":"Antidepressants during pregnancy and lactation: defining exposure and treatment issues","volume":"25","author":"Newport","year":"2001","journal-title":"Semin. Perinatol."},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0140","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1176\/appi.ajp.2012.11111721","article-title":"Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression","volume":"169","author":"Nulman","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0145","doi-asserted-by":"crossref","first-page":"e1002160","DOI":"10.1371\/journal.pmed.1002160","article-title":"Pregnancy-associated changes in pharmacokinetics: a systematic review","volume":"13","author":"Pariente","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0150","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/JCP.0000000000000308","article-title":"Suicide attempt during late pregnancy with quetiapine: nonfatal outcome despite severe intoxication","volume":"35","author":"Paulzen","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0155","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/YIC.0000000000000088","article-title":"Lamotrigine in pregnancy - therapeutic drug monitoring in maternal blood, amniotic fluid, and cord blood","volume":"30","author":"Paulzen","year":"2015","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0160","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4088\/JCP.13m08921","article-title":"Venlafaxine and O-desmethylvenlafaxine concentrations in plasma and cerebrospinal fluid","volume":"76","author":"Paulzen","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0165","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00213-014-3717-9","article-title":"Distribution pattern of mirtazapine and normirtazapine in blood and CSF","volume":"232","author":"Paulzen","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/YIC.0000000000000114","article-title":"Measuring citalopram in blood and central nervous system: revealing a distribution pattern that differs from other antidepressants","volume":"31","author":"Paulzen","year":"2016","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2017.01.019","article-title":"Sertraline in pregnancy - therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood","volume":"212","author":"Paulzen","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0180","doi-asserted-by":"crossref","first-page":"b3569","DOI":"10.1136\/bmj.b3569","article-title":"Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study","volume":"339","author":"Pedersen","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0185","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/mp.2013.89","article-title":"Decreased hippocampal volume and increased anxiety in a transgenic mouse model expressing the human CYP2C19 gene","volume":"19","author":"Persson","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0190","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-0028-1103296","article-title":"Placental transfer of SSRI and SNRI antidepressants and effects on the neonate","volume":"42","author":"Rampono","year":"2009","journal-title":"Pharmacopsychiatry"},{"issue":"3\u20134","key":"10.1016\/j.pnpbp.2017.06.030_bb0195","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s13318-010-0021-x","article-title":"Expression of UDP-glucuronosyltransferase 1A4 in human placenta at term","volume":"35","author":"Reimers","year":"2011","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0200","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1017\/S0033291709992194","article-title":"Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data","volume":"40","author":"Reis","year":"2010","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0205","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/hup.599","article-title":"Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression","volume":"19","author":"Reis","year":"2004","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0210","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijdevneu.2014.10.007","article-title":"Assessment of in-utero venlafaxine induced, ROS-mediated, apoptotic neurodegeneration in fetal neocortex and neurobehavioral sequelae in rat offspring","volume":"40","author":"Singh","year":"2015","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0215","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/mp.2012.42","article-title":"Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function","volume":"18","author":"Stingl","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2017.06.030_bb0220","first-page":"640e7-9","article-title":"Are major depression and generalized anxiety disorder associated with intrauterine growth restriction in pregnant women? A case-control study","volume":"33","author":"Uguz","year":"2011","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0225","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/sj.jp.7211290","article-title":"Amniotic fluid: not just fetal urine anymore","volume":"25","author":"Underwood","year":"2005","journal-title":"J. Perinatol."},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0230","series-title":"Environment and Birth Defects","author":"Wilson","year":"1973"},{"key":"10.1016\/j.pnpbp.2017.06.030_bb0235","doi-asserted-by":"crossref","first-page":"e0144474","DOI":"10.1371\/journal.pone.0144474","article-title":"Use of SSRI and SNRI antidepressants during pregnancy: a population-based study from Denmark, Iceland, Norway and Sweden","volume":"10","author":"Zoega","year":"2015","journal-title":"PLoS One"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584617303573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584617303573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T23:12:55Z","timestamp":1602371575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584617303573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":47,"alternative-id":["S0278584617303573"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2017.06.030","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy exposure to citalopram \u2013 Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2017.06.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}